Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Medicamento teratogénico: contraindicado en embarazo
SUSTANCIA: COPLEFOR-B CAP
FORMOTEROL
OHRENCIA® 250 mg es un medicamento de uso intravenoso o subcutáneo que contiene Abatacept
PRINCIPIO ACTIVO: CLONIXINATO DE LISINA
CINITAPRIDA COMP. 1 MG. CAJA C/25 HIDROCLOROTIAZIDA 12.50 MG TELMISARTAN 80.00 MG Medicamento teratogénico: contraindicado en embarazoSUSTANCIA: CINITAPRIDA COMP. 1 MG. CAJA C 25 FABRICANTE: AMSA GENERICO
US$ 2185000.00
US$ 342750.00
US$ 175150.00
US$ 140100.00